Vista Pharmaceuticals has paid GDUFA (Generic Drug User Fee Amendments of 2012) Facility fees payable by the company to US Food & Drug Administration (USFDA). GDUFA is a law designed to speed access to safe and effective generic drugs to the public, and reduce costs to industry.
Vista Pharmaceuticals is engaged in manufacturing and selling of pharmaceutical, medical and veterinary preparations. The company also sells the products to its related companies, which are engaged in the manufacture of formulations.
